“showed a trend”

Worse neuropsychiatric symptoms showed a trend of increasing conversion rates (HR = 1.03; p = 0.057).

MSA samples showed a trend for a decrease in excitatory neuronal estimates in layer 4 (L4, p = 0.057) and a significant decrease for excitatory neurons in layers 5 and 6 (L5/6, p = 0.0009).

Risperidone-OS showed a trend toward a lower hazard relative to asenapine-SL (hazard ratio 0.59; 95% CI: 0.34–1.02; P = 0.057).

Although Q3 showed a trend toward reduced mortality risk relative to Q2, the association did not reach statistical significance (HR: 0.62, 95% CI: 0.38–1.01, p = 0.057).

Busulfan exposure < 59.5 mg × h/L showed a trend toward a higher risk of TRM than exposure ≥59.5 mg × h/L (HR, 0.5; 95% CI, 0.26-0.99; P = .057).

Somatic variants showed a trend for being more damaging as reflected by the phred-scaled combined annotation-dependent depletion (CADD) score ( P = 0.057; Fig. 4B ) and for being located at more conserved positions as indicated by the genomic evolutionary rate profiling (GERP) score ( P = 0.062; Fig. 4C ).

Intermediate risk patients also showed a trend towards shorter PFS (HR: 2.05, CI: 0.98-4.29, p=0.057) compared to favorable risk patients.

Although overweight status (BMI >25.0) was not significantly different between the two IBS clusters, IBS1 [m(sd), 25.52 (5.68)] showed a trend ( t (27) = 1,99, p = .057) toward greater BMI compared to HC-like IBS [20.99 (6.51)], Hedge’s effect size g (Cohen’s d corrected for small sample sizes) = .74.

CRO showed a trend toward worst outcomes (modified Rankin scale 3–6) at 3 months (OR 3.4, 95% CI 0.96–12, p =0.057).

Means SUDS at T1 and T2 were higher in Controlled Crying, compared to the other two groups which was significant at T1 ( p = 0.01 ) and showed a trend at T2 ( p = 0.057) (Table 5 ).

Interaction between GROUP and GVS was not significant (p = 0.674), neither was GROUP × VS ( p = 0.75), the three-way interaction GROUP × GVS × VS showed a trend ( F (6, 312) = 2.06, p = 0.057, η 2 = 0.008, Fig. 5 B).

Moreover, the LC group showed a trend toward a decrease in leukocyte number (white blood cell; P = 0.057).

Clinical results At day two following treatment, ketamine significantly improved MADRS scores (mean difference -6.5 [95% CI -10.6 to -2.5]; paired t -test, p = 0.003), TEPS-anticipatory scores (mean difference 6.8 [95% CI 2.9 to 9.5]; paired t -test, p = 0.038), TEPS-consummatory scores (mean difference 5.6 [95% CI 1.8 to 6.1]; paired t -test, p = 0.018) and showed a trend to improve SHAPS scores (mean difference -5.2 [95% CI -10.7 to 0.2]; paired t -test, p = 0.057) compared to placebo (Supplementary Fig.

Post-operative complications showed a trend towards statistical significance with younger women having greater proportions compared to elderly (6.5% vs 2.6%, P = 0.057).

IL-4, IL-10, IL-17F and TNF) did not show significant association with malaria infection and clinical episodes, although rs1800890 SNPs in IL-10 gene showed a trend towards increased susceptibility to malaria infection or clinical episode in multivariate analysis ( P = 0.057 and P = 0.052, respectively).

Results The CYP superfamily showed a trend toward association with total lesion count ( P =0.057) and large lesion count ( P =0.088) in contrast to the MMP superfamily.

Compared to the control group, SMT participants improved their fall risk score ( p = 0.036), proprioception ( p = 0.015), reaction time ( p = 0.003), sit-to-stand performance ( p = 0.011) and executive functioning ( p = 0.001), while KIN participants improved their muscle strength ( p = 0.032) and vision ( p = 0.010), and showed a trend towards improved fall risk scores ( p = 0.057).

GABA-currents recorded in KO UNT-oocytes showed a trend towards a decrease with respect to WT UNT-injected oocytes ( Fig. 6f , WT UNT, 100 ± 3.51%, n = 90; KO UNT, 87.21 ± 5.93%, n = 77, p = 0.057), while EC 50 and n H ( Fig. 6g ) remained similar (WT UNT, EC 50 = 93.74 ± 5.21 μM, n H = 1.16 ± 0.05, n = 13; KO UNT, EC 50 = 97.8 ± 4.30 μM, n H = 1.24 ± 0.06, n = 18).

The subsequent RM-ANOVA analysis performed to evaluate the metabolic programming effects of CCX within the diet groups, showed a trend towards an interaction between time and metabolic programming effect ( p = 0.057, RM-ANOVA) and towards a metabolic programming effect ( p = 0.089, RM-ANOVA) only in CAF-fed animals ( Figure 3 A).

In addition, absolute CD4 + T cell counts showed a trend towards decreased naïve CD4 + T cells ( p = 0.057), which was not observed in naïve CD8 + T cells ( Figure 4 b).

Indeed, isolates of ST5 were significantly more active in hemolysis compared to all other strains (p = 0.002), while ST2 showed a trend towards less hemolysis (p = 0.057)( Fig 4 ).

When the association between DPB1 and GPA/PR3-AAV was examined, DPB1*04 : 01 (the risk allele for GPA in European populations) also showed a trend for association with predisposition to PR3-AAV in the Japanese population (P = 0.057, OR = 1.89, 95%CI: 1.03–3.45) ( Table 4 ).

Duration of allogrooming of the stimulus animal showed a trend level interaction of drug condition and sex ( F 1,91 = 3.73, p = 0.057).

The incidence of postoperative nausea showed a trend toward reduction in the conventional meta-analysis (RR 0.49, 95% CI 0.23–1.04; p = 0.057; I 2 = 34%); although TSA suggested a possible benefit, this finding should be considered exploratory.

Anti-VCP1, anti-VCP2, anti-HCP1, and anti-HCP2 IgG in relation to risk factors for disease development and radiological damage HLA- DRB1 -SE was associated with anti-VCP2 ( p < 0.05), and showed a trend for association with anti-HCP2 antibodies ( p = 0.057) in pre-symptomatic individuals.